TEVOGEN BIO HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM)

Tevogen Bio reports a net loss of $26.3 million for the fiscal year 2025

Tevogen advancing strategic CRO evaluation to expand clinical research delivery and drive revenue growth

Tevogen Accelerates Progress on TVGN 489 Long-COVID Project

Agape ATP

Liminatus Pharma

NewGenIvf

Tradr 2X Long QBTS Daily ETF

Defiance Daily Target 2X Long RGTI ETF

Tradr 2X Long RGTI Daily ETF

Sunshine Biopharma

Infleqtion

Wheeler Real Estate

Defiance 2X Daily Long Pure Quantum ETF

TVGNW

TVGN

IBBQ

SBIO

LABU

Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock News

StockTitan

Tevogen Bio

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Direxion S&P Biotech Bear 3X

Invesco Nasdaq Biotechnology ETF

iShares Biotechnology ETF

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock News

Earnings Watch

TEVOGEN BIO HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 0

QUCY

STAA

WGRX

DOCS

IPHA

MDXH

In Thursday's pre-market session, several health care stocks experienced significant movements. Alpha Compute (ALP) surged 71.3% to $0.46, while Innate Pharma (IPHA) rose 24.24% to $1.64. Quantum Cyber (QUCY) increased by 23.88% to $1.66, and Staar Surgical (STAA) gained 21.32% to $35.67. Conversely, MDxHealth (MDXH) fell 41.0% to $1.15, and WORK Medical Tech (WOK) dropped 27.9% to $1.99. Other notable losers included Doximity (DOCS) down 23.43% to $17.91 and Wellgistics Health (WGRX) down 17.53% to $0.08. Earnings reports influenced these movements.

benzinga_article

Quantum Cyber NV

STAAR Surgical

Alpha Compute

WORK Medical Tech

Wellgistics Health

Doximity

Innate Pharma SA

MDxHealth SA

GT Biopharma

Cormedix

Regenxbio

Mainz Biomed NV

SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Tevogen Bio Holdings Inc. (TVGN) is nearing completion of its AI model, PredicTcell, which is designed to identify immunologically active peptides for drug discovery. The model has shown a 10% improvement in precision and the company is exploring co-development partnerships to enhance its application. An internal application for PredicTcell has been developed, aiming to streamline workflows and potentially serve customers. The company also executed a 1-for-50 reverse stock split, with shares closing at $7.00, down 7.28%.

nasdaq

Nasdaq

Tevogen.AI's PredicTcell Model Nears Completion As Company Begins Commercial Readiness Work

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal | TVGN Stock News

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal | TVGN Stock News

ATRA

SPRB

SPRC

TOVX

XRTX

In Tuesday's pre-market session, several health care stocks experienced significant movements. Notable gainers included SciSparc (SPRC), which rose 51.8% to $6.42, and XORTX Therapeutics (XRTX), up 42.22% to $3.2. Other gainers included Tevogen Bio Holdings (TVGN) at $9.88 (+19.03%) and Atara Biotherapeutics (ATRA) at $5.54 (+11.02%). Conversely, Theriva Biologics (TOVX) saw a decline of 23.0% to $0.32, while Spruce Biosciences (SPRB) fell 20.6% to $55.5. Overall, the session highlighted notable volatility in health care stocks.

Atara Biotherap

Spruce Biosciences

SciSparc

Theriva Biologics

XORTX Therapeutics

Xtant Med

Q32 Bio

Clearmind Medicine

Bio Green Med Solution

Jupiter Neurosciences

Foghorn Therapeutics

SPRUCE BIOSCIENCES INC

BIO GREEN MED SOLUTION INC. 6% CNV PFD USD

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth | TVGN Stock News

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth | TVGN Stock News

TEVOGEN BIO HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM)(TVGNW.US)

Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock News

TEVOGEN BIO HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 0

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Tevogen.AI's PredicTcell Model Nears Completion As Company Begins Commercial Readiness Work

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal | TVGN Stock News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth | TVGN Stock News